Research study: Real-World Racial Variation in Treatment and Outcomes Among Patients with Peripheral Artery Disease

17. February 2025

Peripheral Artery Disease (PAD) is a vascular condition characterized by the narrowing of arteries, leading to reduced blood flow to the arms or legs. Around 20 million Americans are affected by PAD, with the burden mostly impacting rural and underserved communities. These areas, often located in Southern and Western states, have high minority populations. Notably, Black medicare patients with PAD are three times more likely to have a limb amputated than a non-black medicare patient. This significant disparity has been a focal point for researchers Keith C. Ferdinand, Kay Sadik, Richard Browne, Urvi Desai, Patrick Lefebvre, Dominique Lejeune, Malena Mahendran, François Laliberté, Lisa Matay and David G. Armstrong. Their study shed light on the disparities in treatment of PAD patients.

ALPS Founding President Dr. David G. Armstrong highlights the importance of the research:

“This research is vital because it highlights persistent racial disparities in PAD outcomes, even within a commercially insured population. By illuminating these gaps, we can inform targeted strategies to reduce inequities and improve outcomes for all patients. Moreover, this study emphasizes the importance of examining real-world data to guide clinical and policy decisions, ensuring that no patient group is left behind.”

Furthermore, Armstrong suggested these steps to prevent disparities in health care

How do we prevent disparities in health care?
  1. Early Diagnosis and Risk Stratification: Enhancing access to diagnostic tools and early intervention programs in underserved communities is critical.
  2. Tailored Treatment Plans: Developing culturally competent care models that address social determinants of health and patient-specific risk factors.
  3. Policy and Advocacy: Advocating for equitable healthcare policies that prioritize preventive care and resource allocation for high-risk populations.
  4. Community Engagement: Partnering with community leaders and organizations to promote awareness about PAD and associated risks, particularly in Black communities.
  5. Furthermore, Armstrong suggested these steps to prevent disparities in health care

 

Patient Resources

Dr. Keith C. Ferdinand, Professor of Medicine, co-author and researcher, remarked on the importance of the research:

“The importance of doing this research is to reveal areas which need special attention to address disparities. The results of this real-world study suggest that Black patients with PAD have a higher disease severity at the time of diagnosis and are at increased risk of experiencing adverse outcomes following diagnosis. Even more importantly, this was an insured population.  If patients have no insurance, are underinsured, or lose insurance, their outcomes may be worsened. “

Research Overview

The PubMed study Real-World Racial Variation in Treatment and Outcomes Among Patients with Peripheral Artery Disease evaluates trends in diagnostic testing, treatment patterns, and outcomes after diagnosis of PAD.

The authors identified 454.382 (68%) white patients and 96.162 (14%) black patients for this study. Even though the black patients on average were younger (71.8 years vs. 74.2 years), they experienced more severe PAD-related risk factors. Results of this real-world study suggest that black patients with PAD have higher disease severity at the time of diagnosis and are at an increased risk of experiencing adverse outcomes following diagnosis 

The study showed that black patients presented with higher disease severity and comorbid burdens at the time of diagnosis compared to white patients. Moreover, they had higher utilization rates of cardiovascular medications at baseline but faced an increased risk of major adverse limb events (MALE) and cardiovascular events, except for myocardial infarction.

Additionally, recent studies found that Black Americans were less likely to be offered preventive procedures to salvage affected limbs thus avoiding amputation. These findings could be linked to why black patients present with higher severity of disease at the time of diagnosis, necessitating earlier intervention. These findings point to the potential for unmet needs in comprehensive care for Black patients, despite higher rates of medication use and diagnostic testing. Notably, the study suggests that revascularization procedures, which restore the blood flow in blocked arteries or veins, are more likely to be combined with the medical therapy black patients receive contrary to earlier studies. 

In conclusion, black patients experience a significantly higher disease burden compared to white patients. The authors emphasize the urgent need to address disparities in healthcare delivery and outcomes by delivering earlier diagnosis and effective medical therapy for Black patients with PAD.

 

Awareness of disparities in PAD

Dr. Keith C. Ferdinand said this on how to prevent PAD:

“In order to address these disparities in PAD, we need to apply evidence-based medicine with early diagnosis and evidence-based treatment to all patients,  regardless of race, ethnicity, socioeconomic status, geography, sex/gender, or ability/disability. The removal of these disparities is not just a moral imperative, but a practical necessity to avoid high medical costs, chronic disability, and premature death.”

 

For further insights, explore the full article:

Related Articles

ALPS brings international experts together to turn diabetic neuropathy guidelines into action

Preventing an amputation begins long before a patient develops a limb-threatening wound. For people with diabetes, one of the most important opportunities is recognizing and managing peripheral neuropathy, the nerve damage that can cause pain, diminish protective sensation, and leave a foot injury unnoticed. New publication in JAPMA offers practical recommendations to strengthen early detection, coordinate care and advance limb preservation worldwide.

read more

“As we conclude the ALPS and DFCon Asia Tour, I am incredibly proud of the impact we have made across WUWHS in Malaysia, DFSICON in India, and ASVS in New Delhi.” Reflections from Georgia Krehbiel, MBA, CEO of ALPS

Georgia Krehbiel, MBA, CEO of ALPS’s reflections on the ALPS Asia Tour 2026, a three-week educational tour across Malaysia and India. Supported by Encoll Corporation, the tour equipped healthcare professionals with practical strategies to prevent amputations and improve diabetic foot care.

read more

ALPS celebrates Robert G. Frykberg’s Lifetime Achievement Award for advancing diabetic limb preservation

The American Limb Preservation Society (ALPS) congratulates Robert G. Frykberg, DPM, MPH, on receiving the 2026 Lifetime Achievement Award from the Diabetic Foot Society of India at DFSICON in Bangalore. The award recognizes nearly five decades of contributions to diabetic foot care, limb preservation, clinical research, and the prevention of avoidable amputations. A respected educator and mentor, Frykberg has helped shape generations of specialists worldwide while advancing interdisciplinary approaches to diabetic limb preservation. His achievements reflect ALPS’s mission to improve outcomes for people at risk of diabetes-related limb loss through research, education, collaboration, and access to specialized care.

read more